6ZK-25863-00645
3 vaccinations
2 coded responses
15 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 928 / CA
- Registered
- 2021-08-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Dose 1 — Pfizer-BioNTech
-
2021-02-05
Dose 2 — Pfizer-BioNTech
-
2021-08-01
Registered in v-safe
- 2021-08-08
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-04
- 2021-10-11
-
2021-10-18
Survey response — day 21, dose 3MedDRA: Lacrimation increased, Nasopharyngitis, Rhinorrhoea — Feeling: FairFree text: Running nose and watery eyes. I caught a cold.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-25
- 2021-11-01
- 2021-11-10
- 2021-12-27
- 2022-03-28
-
2022-09-27
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid 19MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | No |
| 2 | 2021-02-05 | Pfizer-BioNTech | No |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
Free text
Release 10 — day 21, dose 3
Symptoms: Running nose and watery eyes. I caught a cold.
Release 12 — 12 months, dose 3
Symptoms: Covid 19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release